Phytotherapy of mood disorders: studies on the role of probiotics in biotransformation of plant compounds
Planta Medica · 01.03.2026 · 92 (03) · 398
DOI: 10.1055/s-0045-1815403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von A Tymoszewska und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Herbal extracts have long been used to manage mood disorders, with many showing strong clinical evidence for their effectiveness. Nevertheless, the mechanisms of their action and the active compounds remain unknown [ 1 ]. Recent research highlights the crucial role of gut microbiota in the biotransformation of plant compounds into new bioactive metabolites, known as postbiotics [ 2 ] [ 3 ] [ 4 ]. However, there is still a lack of research on the role of probiotics in the biotransformation of plant compounds and their impact on the phytotherapy. This study investigates the biotransformation of plant compounds of four herbal extracts – Valeriana officinalis L. root, Passiflora incarnata L. herb, Piper methysticum G. Forst . rhizome, and Humulus lupulus L. female inflorescences – by selected, comercially available probiotics. Phytochemical analysis confirmed the presence of characteristic plant compounds, including iridoid glycosides, valepotriates, flavonoids, caffeic acid derivatives, kavalactones, flavokavains and bitter acids, in the extracts. Biotransformation studies indicated potential role of probiotics in the metabolism of plant compounds. Lacticaseibacillus rhamnosus strain was responsible for the formation of two postbiotics, C-glycoside derivatives of apigenin and luteolin, from compounds of Passiflora incarnata extract. Additionally, Lactobacillus helveticus, Bifidobacterium longum and Saccharomyces boulardii strains, were implicated in the metabolism of iridoid glycosides and bitter acids. However, major kavalactones, including kavain, 7,8-dihydrokavain, desmethoxyyangonin, yangonin, and dihydromethysticin, remained unaltered by all probiotic strains. These findings suggest that probiotics may influence the bioavailability and pharmacological activity of compounds of mood-modulating herbal extracts. Further studies into combined herbal-probiotic therapies could offer a promising approach for treatment of mood disorders. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Tymoszewska, A., Lech, A., Granica, S., & Piwowarski, J. (2026). Phytotherapy of mood disorders: studies on the role of probiotics in biotransformation of plant compounds. Planta Medica, 92(03), 398. https://doi.org/10.1055/s-0045-1815403
Vancouver
Tymoszewska A, Lech A, Granica S, Piwowarski J. Phytotherapy of mood disorders: studies on the role of probiotics in biotransformation of plant compounds. Planta Medica. 2026;92(03):398. doi:10.1055/s-0045-1815403
BibTeX
@article{Tymoszewska2026,
author = {Tymoszewska, A and Lech, A and Granica, S and Piwowarski, J},
title = {Phytotherapy of mood disorders: studies on the role of probiotics in biotransformation of plant compounds},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {398},
doi = {10.1055/s-0045-1815403}
}
EUVIMED